🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

TXMD TXMD

Company Profile ↓
$2.07
+86.49% 1Y
Mkt Cap$23.96M
P/E-41.40
P/B0.89
52W High$2.77
52W Low$1.04
Book Value$2.32
EPS (TTM)$-0.05

Company Overview

TXMD (TXMD) is a publicly traded company listed on with a market capitalization of $23.96M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.23.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $3.02M (+71.6% YoY); net profit $-569.00K.
  • Trailing 12 Months Year-on-year growth — revenue +71.6%.
  • 5-Year Trend Long-term compounding — revenue CAGR 2.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:2.88%
1 Year:71.61%

Stock Price Performance

1 Year:+86.49%
6 Months:-11.16%
3 Months:+0.00%
1 Month:+5.08%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 60% of range
$1.04 $2.77
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)53.10 · Neutral
Price Performance
1M+5.08%
3M+0.00%
6M-11.16%
1Y+86.49%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading 25.3% below its 52-week high.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-41.40
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$2.32
Price to Book
0.89
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
2.88%
Profit 5Y
-
Revenue (YoY)
71.61%
Earnings (YoY)
-

Profitability & Returns

ROCE
-12.82%
ROE
-2.12%
ROA
-1.51%
Profit Margin
-18.83%
Op Margin
-
Gross Margin
43.08%
EPS (Latest Qtr)
$0.01
EPS (TTM)
$-0.05

Balance Sheet & Liquidity

Debt/Equity
0.23
Quick Ratio
1.43
Current Ratio
3.02
Debt
$6.10M
Total Assets
$37.58M
Current Assets
$15.26M
Working Capital
$9.66M

Ownership

Promoter Holding
7.45%
Chg in Prom Hold
-
FII / Inst Holding
34.02%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$3.02M
EBITDA
$-3.02M
Free Cash Flow
$2.45M
Operating Cash Flow
$2.45M
Shares Outstanding
11.57M
Gross Margin
43.08%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ------3.98M4.25M4.42M4.12M3.77M3.76M3.47M5.09M3.95M6.08M23.72M15.90M12.25M10.70M19.34M22.58M19.87M23.00M25.41M18.68M695.00K348.00K354.00K416.00K437.00K-53.00K---393.00K952.00K784.00K893.00K724.00K
Cost of Revenue ----------------------------------------
Gross Profit 4.00M4.39M3.82M3.27M4.30M3.78M3.33M3.57M3.72M3.53M3.14M3.31M2.77M4.14M3.18M4.83M22.27M13.02M9.54M6.30M16.06M17.00M15.18M18.87M20.12M13.94M14.47M00416.00K437.00K-53.00K--------
Operating Expenses -----------------------------------1.59M1.65M1.61M2.39M1.45M
Operating Income -19.50M--20.97M-21.21M-25.13M--21.29M-19.83M-14.83M--24.72M-33.02M-34.36M--38.11M-41.64M-27.07M--50.92M-45.04M-24.97M-34.61M-29.28M-35.18M-39.92M-35.39M-17.88M-14.86M-14.52M-2.67M-2.47M-1.77M-1.14M-2.79M-1.13M-1.19M-695.00K-830.00K-1.50M-723.00K
EBITDA ------------------------------------1.10M643.00K149.00K-3.24M-629.00K
Interest Expense -----------------------------------2.00K2.00K3.00K--
Pretax Income ------------------------------------668.00K545.00K50.00K-580.00K103.00K
Tax Provision ------------------------------------32.00K0032.00K0
Net Income -19.47M-17.48M-20.93M-21.09M-25.02M-22.84M-21.16M-19.68M-14.66M-21.43M-24.40M-33.22M-35.60M-39.39M-39.51M-55.24M-31.97M-49.44M-56.85M-51.98M-32.61M-42.09M-39.38M-42.65M-47.42M-42.96M-49.02M112.28M-28.96M-3.60M-2.41M-3.38M-734.00K-1.09M-609.00K-653.00K551.00K152.00K-619.00K95.00K
Diluted EPS ------------------------5.41-5.62--5.7012.83-3.13-0.37-0.24-0.32-0.06-0.09-0.05-0.060.050.01-0.01
R&D Expense 16.42M-15.10M13.84M14.66M-7.72M8.72M6.44M-7.04M6.80M6.71M-6.32M4.96M4.08M-3.27M2.74M2.03M-2.05M2.01M1.60M-1.40M1.58M1.11M-----------

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -2.09M3.82M8.78M15.03M20.14M19.36M16.78M16.10M49.65M64.87M-69.96M1.30M1.76M3.02M
Cost of Revenue -----------1.40M1.40M0--
Gross Profit -1.14M2.47M6.82M11.35M15.64M15.17M14.14M13.36M43.31M48.90M1.17M68.57M1.30M--
Operating Expenses ------------57.90M9.82M6.61M7.24M
Operating Income --5.43M-16.15M-25.81M-54.04M-85.19M-90.25M-77.63M-130.22M-151.21M-155.54M-10.66M-8.52M-4.84M-4.21M
EBITDA ------------11.86M-7.60M-3.56M-3.02M
Interest Expense -----------22.57M----
Pretax Income ------------1.07M-7.74M-2.34M-653.00K
Tax Provision ------------0-43.00K-31.00K0
Net Income -2.87M-12.91M-35.12M-28.42M-54.22M-85.08M-89.88M-76.93M-132.62M-176.15M-183.52M-112.00M-10.28M-2.18M-569.00K
Diluted EPS ------------11.96-0.98-0.19-0.05
R&D Expense -107.24K4.49M13.55M43.22M72.04M53.94M33.85M27.30M19.79M10.43M7.09M----

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --1.44M5.93M62.02M59.08M73.73M142.47M143.23M211.98M265.99M181.61M-90.46M43.31M38.82M37.66M
Current Assets -------------55.35M11.80M12.26M14.45M
Cash & Equivalents -422.94K126.42K----------38.07M4.33M5.06M7.48M
Inventory ------------7.62M----
Receivables ------------36.18M----
Total Liabilities --3.15M7.36M7.32M---13.32M114.46M256.78M305.61M-55.31M14.02M11.45M10.78M
Current Liabilities --3.15M3.62M7.32M10.69M10.67M14.98M13.32M41.08M53.00M59.24M-46.84M6.85M5.17M4.79M
Long Term Debt ---------73.38M194.63M237.70M-----
Total Debt -------------8.76M8.01M7.17M6.10M
Total Equity 483.63K964.41K-1.71M-1.43M54.70M48.39M63.06M127.49M129.91M97.52M9.20M-124.00M-35.14M29.29M27.37M26.88M
Shares Outstanding -------------9.50M11.53M11.53M11.57M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -4.97M-12.74M-20.77M-45.52M-79.04M-69.14M-76.16M-106.81M-165.72M-159.47M-9.36M-23.08M1.17M2.45M
Investing Cash Flow -37.64K-272.51K-583.56K-606.76K-584.36K-1.26M-827.11K-21.50M-23.89M-1.60M-2.22M-355.00K0--
Financing Cash Flow 4.71M14.44M73.99M43.30M92.97M137.23M72.58M162.79M188.83M80.72M129.55M-235.21M3.15M0-
Capital Expenditure -28.77K-66.41K-40.79K-30.96K-165.26K-396.15K-61.82K-217.04K-2.45M-207.00K-2.22M-355.00K---
Free Cash Flow -5.00M-12.80M-20.81M-45.55M-79.21M-69.54M-76.22M-107.03M-168.17M-159.68M-9.00M-23.08M1.17M2.45M
Net Change in Cash ------------15.80M-44.99M732.00K2.42M

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -54.6%64.7%77.7%75.6%77.6%78.4%84.3%83.0%87.2%75.4%-98.0%100.0%--
Operating Margin % --259.9%-423.0%-294.1%-359.6%-422.9%-466.3%-462.7%-808.8%-304.6%-239.8%-15.2%-654.6%-275.1%-139.4%
Net Margin % --618.4%-919.9%-323.8%-360.8%-422.4%-464.3%-458.5%-823.7%-354.8%-282.9%-160.1%-789.4%-123.9%-18.8%
ROE % -297.3%754.3%2,450.6%-52.0%-112.0%-134.9%-70.5%-59.2%-136.0%-1,914.4%148.0%-318.7%-35.1%-8.0%-2.1%
ROCE % -317.0%-700.2%-47.2%-111.7%-135.1%-70.8%-59.8%-76.2%-71.0%-127.1%-24.4%-23.4%-14.4%-12.8%

Shareholding Pattern

Insiders
7.45%
Institutions
34.02%
Public Float
36.75%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for TXMD

Yahoo Finance Wed, 12 Nov 2025

TherapeuticsMD: Q3 Earnings Snapshot

BOCA RATON, Fla. AP) — TherapeuticsMD Inc. TXMD) on Wednesday reported earnings of $152,000 in its third quarter.

Yahoo Finance ue, 12 Aug 2025

TherapeuticsMD: Q2 Earnings Snapshot

BOCA RATON, Fla. AP) — TherapeuticsMD Inc. TXMD) on Tuesday reported net income of $551,000 in its second quarter.

TXMD — Frequently Asked Questions

What is the current share price of TXMD?

As of 2026-08-05 17:25 PDT, TXMD trades at $2.07 on NASDAQ/NYSE. Its 52-week range is $1.04 to $2.77.

What is the market capitalisation of TXMD?

TXMD has a market capitalisation of $23.96M on NASDAQ/NYSE.

What is the P/E ratio of TXMD?

TXMD trades at a trailing price-to-earnings (P/E) ratio of -41.40. Its price-to-book (P/B) ratio is 0.89.

What is the return on equity (ROE) of TXMD?

TXMD has a return on equity (ROE) of -2.12%. Its return on capital employed (ROCE) is -12.82%.

Is TXMD a good stock to buy?

This page provides a data-driven analysis of TXMD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space